Gabrielle brings 20 years’ of cross-industry management experience in US- and Australian-led, multi-centre clinical studies and early phase investigator-initiated research in diabetes (device) and gastroenterology (vaccine). She has a biomedical background and notable success in technical projects with a variety of university and industry stakeholders in the biotechnology and medical technology industries. Gabrielle is passionate about research that improves patient treatment options and outcomes.